These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10853284)

  • 1. Using compartmentalized inhalation physiologically-based pharmacokinetic modeling to calculate occupational and environmental risks: a case study involving toluene.
    Giardino NJ; Wilkes CR; Ricci PF; Wireman JR
    Appl Occup Environ Hyg; 2000 Jun; 15(6):457-62. PubMed ID: 10853284
    [No Abstract]   [Full Text] [Related]  

  • 2. Modeling VOC-odor exposure risk in livestock buildings.
    Liang HM; Liao CM
    Chemosphere; 2007 Jun; 68(4):781-9. PubMed ID: 17300829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Occupational monitoring of lung cancer in epidemiologic studies].
    Szadkowska-Stańczyk I; Szeszenia-Dabrowska N
    Med Pr; 2001; 52(1):27-34. PubMed ID: 11424745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toluene determination in capillary blood as a biological indicator of exposure to low levels of toluene.
    Kostrzewski P; Piotrowski JK
    Pol J Occup Med Environ Health; 1991; 4(3):249-59. PubMed ID: 1819343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of human variability on the biological monitoring of exposure to toluene: I. Physiologically based toxicokinetic modelling.
    Tardif R; Droz PO; Charest-Tardif G; Pierrehumbert G; Truchon G
    Toxicol Lett; 2002 Aug; 134(1-3):155-63. PubMed ID: 12191874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of potential toxicity from co-exposure to three CNS depressants (toluene, ethylbenzene, and xylene) under resting and working conditions using PBPK modeling.
    Dennison JE; Bigelow PL; Mumtaz MM; Andersen ME; Dobrev ID; Yang RS
    J Occup Environ Hyg; 2005 Mar; 2(3):127-35. PubMed ID: 15764536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of exposure in epidemiological studies: the example of silica dust.
    Dahmann D; Taeger D; Kappler M; Büchte S; Morfeld P; Brüning T; Pesch B
    J Expo Sci Environ Epidemiol; 2008 Sep; 18(5):452-61. PubMed ID: 18059424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling interchild differences in pharmacokinetics on the basis of subject-specific data on physiology and hepatic CYP2E1 levels: a case study with toluene.
    Nong A; McCarver DG; Hines RN; Krishnan K
    Toxicol Appl Pharmacol; 2006 Jul; 214(1):78-87. PubMed ID: 16464483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of predictive model to estimate concentrations of chemical substances in the work environment].
    Kupczewska-Dobecka M; Czerczak S; Jakubowski M; Maciaszek P; Janasik B
    Med Pr; 2010; 61(3):307-14. PubMed ID: 20677430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose conversion factors for radon: recent developments.
    Marsh JW; Harrison JD; Laurier D; Blanchardon E; Paquet F; Tirmarche M
    Health Phys; 2010 Oct; 99(4):511-6. PubMed ID: 20838092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological monitoring: the role of toxicokinetics and physiologically based pharmacokinetic modeling.
    Mason H; Wilson K
    Am Ind Hyg Assoc J; 1999; 60(2):237-42. PubMed ID: 10222574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Individual susceptibility to occupational carcinogens: the evidence from biomonitoring and molecular epidemiology studies].
    Pavanello S; Clonfero E
    G Ital Med Lav Ergon; 2004; 26(4):311-21. PubMed ID: 15584438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update of potency factors for asbestos-related lung cancer and mesothelioma.
    Berman DW; Crump KS
    Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomonitoring Equivalents (BE) dossier for toluene (CAS No. 108-88-3).
    Aylward LL; Barton HA; Hays SM
    Regul Toxicol Pharmacol; 2008 Aug; 51(3 Suppl):S27-36. PubMed ID: 18583006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Occupational risk factors for lung cancer--a case-control study, Lódź industrial center].
    Swiatkowska B; Szeszenia-Dabrowska N; Sobala W; Wilczyńska U
    Med Pr; 2008; 59(1):25-34. PubMed ID: 18663892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analyses of occupational exposure as a painter and lung and bladder cancer morbidity and mortality 1950-2008.
    Bachand A; Mundt KA; Mundt DJ; Carlton LE
    Crit Rev Toxicol; 2010; 40(2):101-25. PubMed ID: 20085479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining physiologically based pharmacokinetic modeling with Monte Carlo simulation to derive an acute inhalation guidance value for trichloroethylene.
    Simon TW
    Regul Toxicol Pharmacol; 1997 Dec; 26(3):257-70. PubMed ID: 9441916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of human variability on the biological monitoring of exposure to toluene, phenol, lead, and mercury: II. Compartmental based toxicokinetic modelling.
    Pierrehumbert G; Droz PO; Tardif R; Charest-Tardif G; Truchon G
    Toxicol Lett; 2002 Aug; 134(1-3):165-75. PubMed ID: 12191875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung cancer risk associated with occupational exposure to nickel, chromium VI, and cadmium in two population-based case-control studies in Montreal.
    Beveridge R; Pintos J; Parent ME; Asselin J; Siemiatycki J
    Am J Ind Med; 2010 May; 53(5):476-85. PubMed ID: 20187007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of exposure assessment methods for occupational carcinogens in a multi-centre lung cancer case-control study.
    Peters S; Vermeulen R; Cassidy A; Mannetje A'; van Tongeren M; Boffetta P; Straif K; Kromhout H;
    Occup Environ Med; 2011 Feb; 68(2):148-53. PubMed ID: 20871102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.